Valor del FibroScan en el seguimiento de los pacientes con infección crónica por virus B sin indicación de tratamiento

Castellano, Gregorio; Manzano, María Luisa.
Gastroenterol. hepatol. (Ed. impr.) ; 37(supl.2): 15-21, jul. 2014. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-137577

Documentos relacionados

  1. A Clinic Study on Long-term Efficacy and Safety of Autologous Peripheral Blood Stem Cell Transplantation in Patients with Decompensated Hepatitis B Cirrhosis.
  2. Does Hepatitis B Virus Affect the Coagulation Parameters for HBV-Related Decompensated Cirrhosis?
  3. Peripheral Blood Cell Ratios as Prognostic Predictors of Mortality in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis.
  4. Fulminant hepatitis due to spontaneous reactivation of virus B in an immunocompetent patient.
  5. Silent HDV epidemics culminates in high levels of liver cirrhosis in endemic region despite 20 years of HBV vaccination.
  6. Diagnostic accuracy of mac-2-binding protein glycosylation isomer for diagnosing hepatitis B-related fibrosis: A meta-analysis.
  7. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis.
  8. Hepatitis delta virus: Disease assessment and stratification.
  9. Platelet-to-white blood cell ratio: A novel and promising prognostic marker for HBV-associated decompensated cirrhosis.
  10. Hepatitis B.